Arriba: Effects of an educational intervention on prescribing behaviour in prevention of CVD in general practice

European Journal of Preventive Cardiology

Volumn 19, Issue 3, 2012, Pages 322-329

  Keller, Heidemarie ^a   Krones, Tanja ^a,b   Becker, Annette ^a   Hirsch, Oliver ^a   Sönnichsen, Andreas C ^c   Popert, Uwe ^d   Kaufmann Kolle, Petra ^e   Rochon, Justine ^f   Wegscheider, Karl ^g   Baum, Erika ^a   Donner Banzhoff, Norbert ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c PARACELSUS MEDICAL UNIVERSITY   (Austria)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

^e AQUA Institute for Applied Quality Improvement and Research in Health Care   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Antihypertensive agents; aspirin; cardiovascular diseases; drug therapy; hydroxymethylglutaryl CoA reductase inhibitors; primary health care

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARRIBA; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONSULTATION; CONTINUOUS MEDICAL EDUCATION; CONTROLLED STUDY; EDUCATIONAL MODEL; EVIDENCE BASED PRACTICE; FEMALE; FOLLOW UP; GENERAL PRACTICE; HEALTH BEHAVIOR; HEALTH EDUCATION; HEALTH PROGRAM; HIGH RISK PATIENT; HUMAN; LOW RISK PATIENT; MALE; MEDICAL DECISION MAKING; NORMAL HUMAN; PATIENT; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT PLANNING;

AGED; ANTIHYPERTENSIVE AGENTS; ATTITUDE OF HEALTH PERSONNEL; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; DECISION SUPPORT TECHNIQUES; DRUG PRESCRIPTIONS; EDUCATION, MEDICAL, CONTINUING; FEMALE; GENERAL PRACTICE; GERMANY; GUIDELINE ADHERENCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; PREVENTIVE HEALTH SERVICES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84865561247     PISSN: 20474873     EISSN: None     Source Type: Journal    
DOI: 10.1177/1741826711404502     Document Type: Article

References (29)

1. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2003 ; 24 (17). 1601-1610
2. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil. 2007 ; 14 (Suppl 2). 1-113
3. Sheridan SL, Crespo E. Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature. BMC Health Serv Res. 2008 ; 8: 60-60
4. Cooney MT, Dudina AL, Graham IM. Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. J Am Coll Cardiol. 2009 ; 54 (14). 1209-1227
5. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008 ; 117 (6). 743-753 (Pubitemid 351640675)
6. Steenkiste van B, Weijden van der T, Stoffers HEJH, Kester ADM, Timmermans DRM, Grol R. Improving cardiovascular risk management: a randomized, controlled trial on the effect of a decision support tool for patients and physicians. Eur J Cardiovasc Prev Rehabil. 2007 ; 14 (1). 44-50
7. O'Connor AM, Bennett CL, Stacey D, Barry M, Col NF, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009 ; 3: CD001431 - CD001431
8. Shared decision-making in health care: Achieving evidence-based patient choice. 2 nd ed. Don Mills, Ontario: Oxford University Press, 2009. Edwards A Elwyn G, ed. Don Mills, Ontario: Oxford University Press ; 2009 :
9. Cooney MT, Dudina A, D'Agostino R, Graham IM. Cardiovascular risk-estimation systems in primary prevention: do they differ? do they make a difference? can we see the future?. Circulation. 2010 ; 122 (3). 300-310
10. Goldman RE, Parker DR, Eaton CB, Borkan JM, Gramling R, Covert RT, Ahern DK. Patients' perceptions of cholesterol, cardiovascular disease risk, and risk communication strategies. Ann Fam Med. 2006 ; 4 (3). 205-212 (Pubitemid 43824793)
11. Sheridan SL, Viera AJ, Krantz MJ, Ice CL, Steinman LE, Peters KE, et al. The effect of giving global coronary risk information to adults: a systematic review. Arch Intern Med. 2010 ; 170 (3). 230-239
12. Coulter A, Ellins J. Effectiveness of strategies for informing, educating, and involving patients. BMJ. 2007 ; 335 (7609). 24-27 (Pubitemid 47066902)
13. Wensing M, Broge B, Kaufmann-Kolle P, Andres E, Szecsenyi J. Quality circles to improve prescribing patterns in primary medical care: what is their actual impact?. J Eval Clin Pract. 2004 ; 10 (3). 457-466 (Pubitemid 39093752)
14. Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess. 2004 ; 8 (6). iii-iv, 1-72
15. Krones T, Keller H, Sönnichsen A, Sadowski EM, Baum E, Wegscheider K, et al. Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial. Ann Fam Med. 2008 ; 6 (3). 218-227 (Pubitemid 351720820)
16. Sullivan LM, Massaro JM, D'Agostino RB. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med. 2004 ; 23 (10). 1631-1660 (Pubitemid 38660414)
17. Man Son Hing M, Laupacis A, O'Connor AM, Biggs J, Drake E, Yetisir E, et al. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation. JAMA. 1999 ; 282 (8). 737-743 (Pubitemid 29404379)
18. Man-Son-Hing M, Laupacis A, O'Rourke K, Molnar FJ, Mahon J, Chan KBY, et al. Determination of the clinical importance of study results: a review. J Gen Intern Med. 2002 ; 17 (6). 469-476 (Pubitemid 34989015)
19. Cohen J Statistical power analysis for the behavioral sciences. Hillsdale: Lawrence Erlbaum Associates ; 1988 :
20. Grissom RJ, Kim JJ Effect sizes for research: A broad practical approach. Mahwah: Lawrence Erlbaum Associates ; 2005 :
21. Mosca L, Linfante AH, Benjamin EJ, Berra K, Hayes SN, Walsh BW, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005 ; 111 (4). 499-510 (Pubitemid 40204436)
22. Smith MA, Cox ED, Bartell JM. Overprescribing of lipid lowering agents. Qual Saf Health Care. 2006 ; 15 (4). 251-257
23. Persell SD, Zei C, Kenzie A, Cameron KA, Zielinski M, Donald M, et al. Potential use of 10-year and lifetime coronary risk information for preventive cardiology prescribing decisions: a primary care physician survey. Arch Intern Med. 2010 ; 170 (5). 470-477
24. Vlek A, Visseren F, Algra A, Soedamah-Muthu S, Moll F, Doevendans P, et al. Trends in vascular risk factors and medication use in patients with various manifestations of vascular diseases or type 2 diabetes mellitus from 1996 to 2007: the Second Manifestations of ARTerial disease study. Eur J Cardiovasc Prev Rehabil. 2010 ; 17 (6). 628-636
25. Hall LM, Jung RT, Leese GP. Controlled trial of effect of documented cardiovascular risk scores on prescribing. BMJ. 2003 ; 326 (7383). 251-252 (Pubitemid 36169586)
26. Grover SA, Lowensteyn I, Joseph L, Kaouache M, Marchand S, Coupal L, et al. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy. Arch Intern Med. 2007 ; 167 (21). 2296-2303
27. van Dis I, Kromhout D, Geleijnse JM, Boer JMA, Verschuren WMM. Evaluation of cardiovascular risk predicted by different SCORE equations: The Netherlands as an example. Eur J Cardiovasc Prev Rehabil. 2010 ; 17 (2). 244-249
28. Graham IM, Stewart M, Hertog MG. Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of Cardiology. Eur J Cardiovasc Prev Rehabil. 2006 ; 13 (5). 839-845 (Pubitemid 44454860)
29. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet.. 2003 ; 362 (9391). 1225-1230 (Pubitemid 37255352)